Under typical market conditions, this fund commits a substantial portion—at least 80%—of its total investable capital (net assets plus any borrowed funds for investment) to equity and equity-linked instruments. These holdings specifically target companies within the healthcare and life sciences sectors, encompassing a range of securities such as common shares, preferred stock, options, and convertible debt. Furthermore, the fund possesses the flexibility to acquire stakes in companies domiciled outside the United States, without any geographical restrictions.
